Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sibutramine and Self-help CBT for Binge Eating in Obese Patients
NCT00537810Phase 4Completed
- Sponsor
- Yale University
- Start
- Sep 2007
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sibutramine in binge eating disorder (BED) and obesity, sponsored by Yale University. Primary endpoint: Binge Eating Remission at 12 months. Started Sep 2007; status: completed.
02
Drugs
sibutramine
03
Conditions
binge eating disorder (BED)obesity
Beyond the preview
Go deeper on NCT00537810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537810.